首页> 外文OA文献 >Sequential treatment with a listeria-based vaccine and PD-1 blockade antibody improves survival in a murine model of pancreatic ductal adenocarcinoma

【2h】

Sequential treatment with a listeria-based vaccine and PD-1 blockade antibody improves survival in a murine model of pancreatic ductal adenocarcinoma

机译：用基于李斯特菌的疫苗和PD-1阻断抗体的顺序治疗改善了胰腺导管腺癌的小鼠模型中的存活

代理获取

本网站仅为用户提供外文OA文献查询和代理获取服务，本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文，但由于OA文献来源多样且变更频繁，仍可能出现获取不到、文献不完整或与标题不符等情况，如果获取不到我们将提供退款服务。请知悉。

页面导航

著录项
引文网络
相似文献
相关主题

著录项

作者
V. Kim; K. Foley; K. Soares; A. Rucki; P. Lauer; D. Brockstedt; C. Wolfgang; E. Jaffee; L. Zheng;
展开▼
作者单位

展开▼
年度 2016
总页数
原文格式 PDF
正文语种
中图分类

相似文献

外文文献
中文文献
专利

1. Sequential administration of MVA-based vaccines and PD-1/PD-L1-blocking antibodies confers measurable benefits on tumor growth and survival: Preclinical studies with MVA-Gal and MVA-MUC1 (TG4010) in a murine tumor model [J] . Remy-Ziller Christelle, Thioudellet Christine, Hortelano Julie, Human vaccines & immunotherapeutics. . 2018,第1期

机译：基于MVA的疫苗和PD-1 / PD-L1阻断抗体的顺序施用对肿瘤生长和存活的可衡量的益处：在鼠肿瘤模型中与MVA-GAL和MVA-MUC1（TG4010）的临床前研究
2. Dinaciclib prolongs survival in the LSL-KrasG12D/+; LSL-Trp53(R172H/+); Pdx-1-Cre (KPC) transgenic murine models of pancreatic ductal adenocarcinoma [J] . International journal of applied mechanics . 2020,第3期

机译：Dinaciclib延长LSL-KRASG12D / +中的存活; LSL-TRP53（R172H / +）; PDX-1-CRE（KPC）胰腺导管腺癌的转基因鼠模型
3. Dinaciclib prolongs survival in the LSL-Kras G12D/+ ; LSL-Trp53 R172H/+ ; Pdx-1-Cre (KPC) transgenic murine models of pancreatic ductal adenocarcinoma [J] . Jia Yang, Su Hu, Junjie Shangguan, American Journal of Translational Research . 2020,第3期

机译：Dinaciclib延长LSL-KRAS G12D / +中的存活; LSL-TRP53 R172H / +; PDX-1-CRE（KPC）胰腺导管腺癌的转基因鼠模型
4. Texture Analysis For Survival Prediction of Pancreatic Ductal Adenocarcinoma Patients with Neoadjuvant Chemotherapy [C] . Jayasree Chakraborty, Liana Langdon-Embry, Joanna G. Escalon, Conference on imaging processing . 2016

机译：纹理分析对胰腺癌新辅助化疗患者生存率的预测
5. Survival signaling and redox regulation in pancreatic ductal adenocarcinoma. [D] . Pham, Nhu-An. 2007

机译：胰腺导管腺癌的生存信号和氧化还原调节。
6. Sequential administration of MVA-based vaccines and PD-1/PD-L1-blocking antibodies confers measurable benefits on tumor growth and survival: Preclinical studies with MVA-βGal and MVA-MUC1 (TG4010) in a murine tumor model [O] . Christelle Remy-Ziller, Christine Thioudellet, Julie Hortelano, 2018

机译：依次施用基于MVA的疫苗和PD-1 / PD-L1阻断抗体可为肿瘤的生长和存活带来可衡量的益处：在小鼠肿瘤模型中使用MVA-βGal和MVA-MUC1（TG4010）进行的临床前研究
7. Combining the Specific Anti-MUC1 Antibody TAB004 and Lip-MSA-IL-2 Limits Pancreatic Cancer Progression in Immune Competent Murine Models of Pancreatic Ductal Adenocarcinoma [O] . Didier Dréau, Laura Jeffords Moore, Mike Wu, 2019

机译：结合特定的抗MUC1抗体Tab004和唇部MSA-IL-2限制胰腺导管腺癌免疫伴小鼠模型的胰腺癌进展

Sequential treatment with a listeria-based vaccine and PD-1 blockade antibody improves survival in a murine model of pancreatic ductal adenocarcinoma

著录项

引文网络

相似文献

相关主题

期刊订阅